Atlas Trials

Titrating-Dose of Lonafarnib in Combination With Ritonavir

Clinical trial NCT02527707 · COMPLETED

Trial details

NCT number
NCT02527707
Sponsor
Eiger BioPharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Delta Hepatitis
Start date
2015-09-01
Primary completion
2016-08-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.